Welcome
Support Centre
13 October 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The prevalence and associations of fatigue in Systemic Lupus Erythematosus (SLE) and the effects of aerobic exercise on fatigue and sleep patterns in SLE
ISRCTN ISRCTN71091471
ClinicalTrials.gov identifier
Public title The prevalence and associations of fatigue in Systemic Lupus Erythematosus (SLE) and the effects of aerobic exercise on fatigue and sleep patterns in SLE
Scientific title
Acronym N/A
Serial number at source T0519
Study hypothesis To test the efficacy of a graded aerobic exercise programme in treating fatigue in systemic lupus erythematosus.
Ethics approval Ethical approval was obtained from the district research ethics committee and all subjects gave valid and informed consent before entering the study.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Systemic lupus erythematosus (SLE)
Participants - inclusion criteria Female patients fulfilling American College of Rheumatology (ACR) classification for SLE
Participants - exclusion criteria 1. Evidence of active severe myositis, nephritis, neurological involvement or cardiac or pulmonary disease
2. Pregnant patients
3. Patients under 16 or over 55 years
Anticipated start date 01/01/2001
Anticipated end date 01/01/2003
Status of trial Completed
Patient information material
Target number of participants 93
Interventions Allocation using a minimisation protocol to 12 weeks of either graded exercise therapy, relaxation therapy or no intervention
Primary outcome measure(s) Self-rated clinical global impression change score, measured at baseline and three months.
Secondary outcome measure(s) 1. Assessments of symptoms, measured at baseline and three months
2. Functional capacity, measured at baseline and three months
3. Fitness, measured at baseline and three months
Sources of funding Arthritis Research Campaign (UK)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12730519
Contact name Dr  David  D'Cruz
  Address The Lupus Research Unit
The Rayne Institute
St Thomas' Hospital
Lambeth Palace Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
Sponsor Arthritis Research Campaign (ARC) (UK)
  Address Copeman House
St Mary's Court
St Mary's Gate
Chesterfield
  City/town Derbyshire
  Zip/Postcode S41 7TD
  Country United Kingdom
  Email info@arc.org.uk
  Sponsor website: http://www.arc.org.uk
Date applied 18/07/2002
Last edited 13/03/2008
Date ISRCTN assigned 18/07/2002
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central